530233 — Auro Laboratories Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapNeutral
- IN₹540.79m
- IN₹487.36m
- IN₹528.94m
- 80
- 45
- 54
- 66
Annual income statement for Auro Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 468 | 438 | 543 | 509 | 529 |
| Cost of Revenue | |||||
| Gross Profit | 182 | 193 | 257 | 181 | 172 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 410 | 387 | 440 | 473 | 496 |
| Operating Profit | 58.3 | 51.4 | 102 | 36.1 | 33.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 60.7 | 56.4 | 105 | 38.7 | 34.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 44 | 40.5 | 71.8 | 28.4 | 24.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 44 | 40.5 | 71.8 | 28.4 | 24.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 44 | 40.5 | 71.8 | 28.4 | 24.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.06 | 6.51 | 11.5 | 4.56 | 3.92 |